Tasly Pharmaceuticals, Inc (Tasly) and BioHealth Innovation (BHI) co-organized the first Tasly Meeting of CEOs on Tuesday, September 2, 2014 at the Tasly facility in Rockville. Attendees included more than 25 CEOs and company representatives from local Maryland-based BioTech and BioPharma companies. This was the first public event conducted through Tasly and BHI's newly initiated partnership.
Tasly is an innovation-based, high-tech healthcare and pharmaceutical enterprise and world-leader in the research and product development (R&D) of Chinese herbal medicine - the leader in the natural way to modernize medicine, with a North American headquarters in Rockville, Maryland, . Tasly and BHI have a formalized partnership which aims to co- organize and coordinate joint BioHealth associated events to promote professional networking, business growth, and technology and product commercialization.
For Tuesday's event, BHI developed a list of meeting attendees and Tasly hosted the event. Dr. Henry Sun, CEO of the Tasly Pharmaceuticals Inc., kicked off the event by welcoming attendees and introducing Tasly; Mr. Richard Bendis, CEO of BHI, and Ms. Lily Qi, Director of the Special Programs for Montgomery County's Office of the County Executive , delivered opening remarks. Dr. Xijun Yan, Founder and Chairman of Tasly Holding Groups, of Tianjin, China, provided his vision related to Tasly's presence in the United States as well as future plans for business development. Dr. Yan expressed an interest in future Tasly collaboration to promote new technologies and add new products to its portfolio.